相关实验视频

Updated: May 28, 2025

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

对成年急性淋巴细胞白血病的发病和治疗潜力的代谢洞察力

Jun-Yu Wang^1,2, Tuan-Tuan Gui^1,3, Bo Jiao¹

¹Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine at Shanghai, Research Unit of Hematologic Malignancies Genomics and Translational Research of Chinese Academy of Medical Sciences, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Proceedings of the National Academy of Sciences of the United States of America

|February 13, 2025

概括

成年急性淋巴细胞白血病 (ALL) 显示胆酸代谢物增加和代谢重新连接. 用simvastatin或FK866等药物准这些代谢途径为ALL提供了新的治疗策略.

科学领域:

代谢学代谢学代谢学
癌症生物学癌症生物学
基因组学就是基因组学.

背景情况:

成年急性淋巴细胞白血病 (ALL) 由于其异质性和耐治疗性而带来了重大挑战.
了解ALL的代谢格局对于开发新型治疗方法至关重要.

研究的目的:

为了研究成年ALL患者的代谢概况.
为了确定与ALL相关的代谢变化.
探索成人ALL的新型代谢干预措施.

主要方法:

对201例新诊断成年ALL病例的细胞内和血清代谢概况的分析.
代谢学和转录学数据的整合,以创建综合代谢信息数据集 (CMID).
在小鼠和患者衍生的异种移植ALL模型中对治疗干预措施的评估.

主要成果:

在血清中胆酸 (BA) 代谢产物的主要增加.
代谢重新连接支持增殖和信号,包括白血病爆发中的核酸代谢.
开发一个集群系统 (CMID) 以帮助风险分层.
与simvastatin,vincristine和dexamethasone观察到的协同治疗效应.
在使用FK866和venetoclax的异种移植模型中延长生存时间.

结论:

代谢分析揭示了成年ALL的关键变化,特别是胆酸的升高.
CMID为了解ALL代谢和改善风险分层提供了宝贵的资源.
准代谢途径,如胆酸代谢和氧化还原代谢,对新型ALL疗法有很大的前景.

关键词:

大人的急性淋巴细胞白血病.综合代谢信息数据集数据集疾病风险分层疾病风险分层.

更多相关视频

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...